STOCKHOLM - August 16, 2018 - ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, released its report for Q2 2018, and reported stable sales and good progress towards its new market, digital pathology. Q2 sales ended at 21,9 MSEK, compared to 22,7 MSEK in the same period last year. The continued expansion of the research R&D program and pre-marketing activities gave a lower result compared to the same quarter last year (-1,2 MSEK), in full accordance with the long-term strategy. `During this quarter we have taken important steps towards our first product and, in parallel, significantly broadened our partnerships to provide unique...
|